TY - JOUR
T1 - Zygomycosis in the 1990s in a tertiary-care cancer center
AU - Kontoyiannis, Dimitrios P.
AU - Wessel, Verena C.
AU - Bodey, Gerald P.
AU - Rolston, Kenneth V.I.
PY - 2000
Y1 - 2000
N2 - Twenty-four patients with cancer met predetermined criteria for a diagnosis of zygomycosis over a 10-year period at our institution. All had hematologic malignancy, and most had either neutropenia or steroid use as a risk factor. Pulmonary involvement mimicking invasive aspergillosis was the most common presentation, and dissemination was seen in 58% of patients on whom autopsies were performed. Three-fourths of the patients with pulmonary zygomycosis had pathogenic microorganisms other than zygomycetes isolated from respiratory specimens. The sensitivity of cultures in detecting zygomycetes from respiratory specimens was low. A culture positive for zygomycetes was typically a preterminal finding in the fatal, acute cases. Two-thirds of the patients died. Favorable outcome seemed to correlate with lack of pulmonary involvement, surgical debridement, neutrophil recovery, and a cumulative total amphotericin B dose of 2000 mg. Therapy with high-dose amphotericin B, combined with aggressive surgery and immune reconstitution, offers the best chance for survival of cancer patients with zygomycosis.
AB - Twenty-four patients with cancer met predetermined criteria for a diagnosis of zygomycosis over a 10-year period at our institution. All had hematologic malignancy, and most had either neutropenia or steroid use as a risk factor. Pulmonary involvement mimicking invasive aspergillosis was the most common presentation, and dissemination was seen in 58% of patients on whom autopsies were performed. Three-fourths of the patients with pulmonary zygomycosis had pathogenic microorganisms other than zygomycetes isolated from respiratory specimens. The sensitivity of cultures in detecting zygomycetes from respiratory specimens was low. A culture positive for zygomycetes was typically a preterminal finding in the fatal, acute cases. Two-thirds of the patients died. Favorable outcome seemed to correlate with lack of pulmonary involvement, surgical debridement, neutrophil recovery, and a cumulative total amphotericin B dose of 2000 mg. Therapy with high-dose amphotericin B, combined with aggressive surgery and immune reconstitution, offers the best chance for survival of cancer patients with zygomycosis.
UR - http://www.scopus.com/inward/record.url?scp=0034464807&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034464807&partnerID=8YFLogxK
U2 - 10.1086/313803
DO - 10.1086/313803
M3 - Article
C2 - 10852735
AN - SCOPUS:0034464807
SN - 1058-4838
VL - 30
SP - 851
EP - 856
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 6
ER -